Literature DB >> 30798661

Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension.

Risa Isonaka1, Avi Z Rosenberg2, Patti Sullivan1, Abraham Corrales1, Courtney Holmes1, Yehonatan Sharabi3, David S Goldstein1.   

Abstract

Lewy body diseases involve neurogenic orthostatic hypotension (nOH), cardiac noradrenergic deficiency, and deposition of the protein AS (alpha-synuclein) in sympathetic ganglion tissue. Mechanisms linking these abnormalities are poorly understood. One link may be AS deposition within sympathetic neurons. We validated methodology to quantify AS colocalization with TH (tyrosine hydroxylase), a marker of sympathetic noradrenergic innervation, and assessed associations of AS/TH colocalization with myocardial norepinephrine content and cardiac sympathetic neuroimaging data in nOH. Postmortem sympathetic ganglionic AS/TH colocalization indices and myocardial norepinephrine contents were measured in 4 Lewy body and 3 rare non-Lewy body nOH patients. Sixteen Lewy body and 11 non-Lewy body nOH patients underwent in vivo skin biopsies and thoracic 18F-dopamine positron emission tomographic scanning, with cutaneous colocalization indices expressed versus cardiac 18F-dopamine-derived radioactivity. Ganglionic AS/TH colocalization indices were higher and myocardial norepinephrine lower in Lewy body than non-Lewy body nOH ( P=0.0020, P=0.014). The Lewy body nOH group had higher AS/TH colocalization indices in skin biopsies and lower myocardial 18F-dopamine-derived radioactivity than did the non-Lewy body nOH group ( P<0.0001 each). All Lewy body nOH patients had colocalization indices >1.5 in skin biopsies and 18F-dopamine-derived radioactivity <6000 nCi-kg/cc-mCi, a combination not seen in non-Lewy body nOH patients ( P<0.0001). In Lewy body nOH, AS deposition in sympathetic noradrenergic nerves is related to postmortem neurochemical and in vivo neuroimaging evidence of myocardial noradrenergic deficiency. These associations raise the possibility that intraneuronal AS deposition plays a pathophysiological role in the myocardial sympathetic neurodegeneration attending Lewy body nOH.

Entities:  

Keywords:  Lewy body diseases; alpha-synuclein; cardiac neuroimaging; orthostatic hypotension; skin biopsy; sympathetic nervous system; tyrosine hydroxylase

Mesh:

Substances:

Year:  2019        PMID: 30798661      PMCID: PMC6472912          DOI: 10.1161/HYPERTENSIONAHA.118.12642

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  46 in total

1.  Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Authors:  David S Goldstein; Courtney Holmes; Patti Sullivan; Deborah C Mash; Ellen Sidransky; Alessandro Stefani; Irwin J Kopin; Yehonatan Sharabi
Journal:  Parkinsonism Relat Disord       Date:  2015-07-17       Impact factor: 4.891

2.  Cardiac sympathetic denervation predicts PD in at-risk individuals.

Authors:  David S Goldstein; Courtney Holmes; Grisel J Lopez; Tianxia Wu; Yehonatan Sharabi
Journal:  Parkinsonism Relat Disord       Date:  2017-10-05       Impact factor: 4.891

3.  The heart of PD: Lewy body diseases as neurocardiologic disorders.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Brain Res       Date:  2017-10-10       Impact factor: 3.252

4.  Three-dimensional reconstructed eccrine sweat glands with vascularization and cholinergic and adrenergic innervation.

Authors:  Mingjun Zhang; Haihong Li; Liyun Chen; Shuhua Fang; Sitian Xie; Changmin Lin
Journal:  J Mol Histol       Date:  2018-04-17       Impact factor: 2.611

5.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

6.  The sympathetic-nervous-system defect in primary orthostatic hypotension.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

7.  Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

Authors:  Satoshi Orimo; Toshiki Uchihara; Ayako Nakamura; Fumiaki Mori; Akiyoshi Kakita; Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Brain       Date:  2007-12-13       Impact factor: 13.501

Review 8.  Structure and function of human sweat glands studied with histochemistry and cytochemistry.

Authors:  Kenji Saga
Journal:  Prog Histochem Cytochem       Date:  2002

9.  Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.

Authors:  Vincenzo Donadio; Alex Incensi; Cristina Piccinini; Pietro Cortelli; Maria Pia Giannoccaro; Agostino Baruzzi; Rocco Liguori
Journal:  Ann Neurol       Date:  2015-12-29       Impact factor: 10.422

10.  The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.

Authors:  Christopher H Gibbons; Jennifer Garcia; Ningshan Wang; Ludy C Shih; Roy Freeman
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

View more
  12 in total

1.  Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.

Authors:  Derek P Narendra; Risa Isonaka; Diana Nguyen; Alice B Schindler; Angela D Kokkinis; Debra Ehrlich; Tanya M Bardakjian; David S Goldstein; Tsao-Wei Liang; Pedro Gonzalez-Alegre
Journal:  Neurology       Date:  2019-04-26       Impact factor: 9.910

Review 2.  The catecholaldehyde hypothesis: where MAO fits in.

Authors:  David S Goldstein
Journal:  J Neural Transm (Vienna)       Date:  2019-12-05       Impact factor: 3.575

Review 3.  Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Authors:  David S Goldstein; Risa Isonaka; Guillaume Lamotte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-10-20       Impact factor: 4.435

4.  Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases.

Authors:  David S Goldstein; Mark J Pekker; Patti Sullivan; Risa Isonaka; Yehonatan Sharabi
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

5.  Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies.

Authors:  Risa Isonaka; Christopher H Gibbons; Ningshan Wang; Roy Freeman; David S Goldstein
Journal:  Clin Auton Res       Date:  2019-10-31       Impact factor: 4.435

6.  In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.

Authors:  Vincenzo Donadio; Zerui Wang; Alex Incensi; Giovanni Rizzo; Enrico Fileccia; Veria Vacchiano; Sabina Capellari; Martina Magnani; Cesa Scaglione; Michelangelo Stanzani Maserati; Patrizia Avoni; Rocco Liguori; Wenquan Zou
Journal:  Neurology       Date:  2021-04-09       Impact factor: 11.800

7.  Cardiac sympathetic innervation and vesicular storage in pure autonomic failure.

Authors:  David S Goldstein; Risa Isonaka; Courtney Holmes; Yu-Shin Ding; Yehonatan Sharabi
Journal:  Ann Clin Transl Neurol       Date:  2020-09-10       Impact factor: 4.511

8.  Synuclein Deficiency Results in Age-Related Respiratory and Cardiovascular Dysfunctions in Mice.

Authors:  Patrick S Hosford; Natalia Ninkina; Vladimir L Buchman; Jeffrey C Smith; Nephtali Marina; Shahriar SheikhBahaei
Journal:  Brain Sci       Date:  2020-08-24

Review 9.  The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.

Authors:  David S Goldstein
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

10.  α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.

Authors:  Risa Isonaka; David S Goldstein; William Zhu; Esther Yoon; Debra Ehrlich; Alice B Schindler; Angela D Kokkinis; Marya S Sabir; Sonja W Scholz; Sara Bandres-Ciga; Cornelis Blauwendraat; Pedro Gonzalez-Alegre; Grisel Lopez; Ellen Sidransky; Derek P Narendra
Journal:  Mov Disord       Date:  2021-06-02       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.